Kamet Ventures

Kamet Ventures is the venture builder and investor arm of AXA, the French global insurance group, with a thesis built around building and backing companies that intersect with insurance, health, and protection. Kamet operates as a hybrid studio and venture fund, sometimes founding companies internally and sometimes investing in independent founders, with checks generally in the EUR 1M to EUR 10M range from seed through Series B. Healthcare exposure is meaningful and concentrated in digital health, telemedicine, mental health, and care delivery models that align with AXA’s health insurance footprint, particularly in France, the UK, and other AXA markets. AI focus is welcome where it improves underwriting, claims, distribution, or care delivery economics. Founders best suited are European and selectively global seed and Series A CEOs in digital health, telemedicine, or insurance technology who can leverage AXA’s insurance distribution and underwriting expertise. Founders who do not fit include therapeutics, devices, US-only digital health teams without an insurance angle, and consumer wellness without an enterprise buyer. Geographic preference is Europe with a French and UK bias. The entry path is warm introduction through an AXA executive, a Kamet Ventures partner, a portfolio CEO, or a French digital health operator. LinkedIn outreach to a Kamet investor with a clear strategic articulation is a reasonable secondary option. Expect strategic questions about integration with AXA’s insurance products alongside standard financial diligence.